Results 111 to 120 of about 3,408 (187)
Sensitivity and specificity of single IgA and IgG antibody concentrations for early diagnosis of pertussis in adults: an evaluation for outbreak management in public health practice [PDF]
, 2007 Background: An accurate, practical laboratory test is needed to confirm clinical diagnosis of pertussis in adults during the first 3 symptomatic weeks, when treatment is effective and transmission can be interrupted.
Mertens, PLJM (Paulus Leonardus Johannes Mar) +3 more
core +1 more source
PROTECTIVE EFFICACY OF PERTACTIN CONTAINING ACELLULAR DPT VACCINES
Вопросы современной педиатрии, 2008 Pertussis vaccination with the use of DPT vaccines is a necessary condition for fighting the infection called bordetella pertussis. At the same time, it is known that the use of whole cellular DPT vaccines is accompanied with high incidence of side effects and serious neurological complications, and, as a result, reasonable refuse from injections by ...
M.V. Fesenko, L.S. Namazova
openaire +2 more sources
Human Vaccines & Immunotherapeutics, 2017 Immunization with the tetanus, diphtheria, and pertussis (Tdap) vaccine raises controversies on immunogenicity and possible antibody interference. We performed an experimental, double-blind, parallel group controlled clinical trial to evaluate the safety
Jesús Zacarías Villarreal Pérez +8 more
doaj +1 more source
Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence?
Emerging Infectious Diseases, 2001 In The Netherlands, as in many other western countries, pertussis vaccines have been used extensively for more than 40 years. Therefore, it is conceivable that vaccine-induced immunity has affected the evolution of B. pertussis.
Frits R. Mooi +2 more
doaj +1 more source
Polymorphism of Pertactin Gene Repeat Regions in Bordetella bronchiseptica Isolates from Pigs
Journal of Veterinary Medical Science, 2007 Bordetella bronchiseptica pertactin (prn) is an outer membrane protein which has been implicated as both an adhesin and a protective antigen that induces immunity against atrophic rhinitis in pigs. Previous studies demonstrated extensive heterogeneity of the prn sequence within two distinct regions of amino acid repeats for B.
Eun-Kyung, Shin +2 more
openaire +3 more sources
BMC Microbiology, 2009 Background Bordetella pertussis is a causative agent of pertussis or whooping cough in humans. Pertactin (Prn), fimbriae 2 (Fim2) and fimbriae 3 (Fim3) of B.
Hou Qiming +7 more
doaj +1 more source
BACKGROUNDAcellular pertussis vaccines replaced whole-cell vaccines for the 5-dose childhood vaccination series in 1997. A sixth dose of pertussis-containing vaccine, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis, adsorbed (Tdap ...
core
P69 pertactin: LRR, PRR and efficacious vaccine [PDF]
Acta Crystallographica Section A Foundations of Crystallography, 1996 P. Emsley +3 more
openaire +1 more source
Determination of Serum Antibody to Bordetella pertussis Adenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults with Pertussis [PDF]
, 2017 Presence of antibody to adenylate cyclase toxin (ACT) has been noted following Bordetella pertussis infection. Because ACT is not presently in any acellular pertussis vaccines, it has been considered as a possible antigen to use in B.
Cherry, James D. +5 more
core
Het Rijksvaccinatieprogramma in Nederland : Surveillance en ontwikkelingen in 2014-2015 [PDF]
, 2017 In Nederland is de vaccinatiegraad binnen het Rijksvaccinatieprogramma (RVP) hoog, waardoor weinig mensen de ziekten krijgen waartegen zij worden ingeënt.
de Melker HE +1 more
core